Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marco Sardella"'
Autor:
Marco Sardella, Glyn Belcher, Calin Lungu, Terenzio Ignoni, Manuela Camisa, Doris Irene Stenver, Paolo Porcelli, Margherita D’Antuono, Nicola Gian Castiglione, Anna Adams, Giovanni Furlan, Ilaria Grisoni, Sarah Hall, Laura Boga, Valentina Mancini, Mircea Ciuca, David Chonzi, Brian Edwards, Arduino A Mangoni, Marco Tuccori, Elena Prokofyeva, Fabio De Gregorio, Mario Bertazzoli Grabinski Broglio, Bert van Leeuwen, Paola Kruger, Christian Rausch, Hervé Le Louet
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Externí odkaz:
https://doaj.org/article/e2f577c0d23646f1bd9f7bce36bd7551
Autor:
Marco Sardella, Calin Lungu
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Different strategies have been studied to allow a better characterization of the safety profile of orphan drugs soon after their approval. At the end of the development phases only few data are available because of the small number of subjects expose
Externí odkaz:
https://doaj.org/article/2f5c0c67c61c43cead79853498bd2704
Autor:
Fabio De Gregorio, Arduino A. Mangoni, Giovanni Furlan, Terenzio Ignoni, Marco Tuccori, Hervé Le Louet, Bert van Leeuwen, Nicola Gian Castiglione, Manuela Camisa, Marco Sardella, Anna L. Adams, Paolo Porcelli, Doris Irene Stenver, Glyn Belcher, Elena Prokofyeva, Valentina Mancini, Brian Edwards, Ilaria Grisoni, Mircea Ciuca, Mario Bertazzoli Grabinski Broglio, Margherita D'Antuono, David Chonzi, Laura Boga, Calin Lungu, Christian Rausch, Paola Kruger, Sarah Hall
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Autor:
Glyn Belcher, Marco Sardella
Publikováno v:
Therapeutic Advances in Drug Safety. 9:631-638
The assessment of the safety of medicines for rare diseases during the development phase is often limited by the few data available from small numbers of patients. This also applies to a lesser extent during the postmarketing phase of the lifecycle o
Publikováno v:
Energy Conversion and Management. 89:925-932
The purpose of this paper is to investigate the feasibility of integrating a proton exchange membrane fuel cell (PEMFC) system with a commercial greenhouse and assess the mutual benefits of such integration. The main objective is to recover the low q
Autor:
Ernst Holler, Dietger Niederwieser, Nancy A. Kernan, Selim Corbacioglu, Paul G. Richardson, Leslie Lehmann, Sergio Giralt, Michelle E. Maglio, Craig Maguire, Marco Sardella, Margaret Hoyle, Vincent T. Ho, Robert J. Soiffer, Enric Carreras
Publikováno v:
Expert Opinion on Drug Safety. 12:123-136
Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), is a potentially life-threatening complication of chemotherapeutic conditioning used in preparation for hematopoietic stem-cell transplantation (SCT). Defibrot
Publikováno v:
Behavioural pharmacology. 21(1)
Evidence from both animal and human studies suggests a role for dopamine in the therapeutic effect of antidepressant drugs. Consistently, dopamine receptor antagonists antagonize the effect of antidepressant drugs in different experimental models of
Autor:
Flavia Franconi, Monni Giuseppina, Maria Elena Canu, Serra Gino, Paolo S. D'Aquila, Davide Carta, Marco Sardella
Publikováno v:
Gender Medicine. 3:S48-S49
Autor:
Paul R. Haut, Stephan A. Grupp, Nancy A. Kernan, Elena Tudone, Paul G. Richardson, Sally Arai, Marco Sardella, Brandon M. Triplett, Dietger Niederwieser, Valeria Bandiera, Leslie Lehmann, Carin Heringa, Alfred P. Gillio, Robert J. Soiffer
Publikováno v:
Blood. 120:3041-3041
Abstract 3041 Background: Given the potentially life-threatening nature of hepatic VOD, the lack of approved treatments for this disease and the increasing evidence indicating that DF leads to improved outcome, DF has been made available on a compass
Autor:
Marco Sardella, Selim Corbacioglu, Robin Hume, Paul G. Richardson, Massimo Iacobelli, Joseph M. Massaro, Alison L. Hannah, Enric Carreras, Dietger Niederwieser, Margaret Hoyle
Publikováno v:
Blood. 116:3482-3482
Abstract 3482 Introduction: Defibrotide (DF), a characterized mixture of polydisperse oligonucleotides, has endothelial protective properties with profibrinolytic, antithrombotic, anti-inflammatory and anti-adhesive activity. The safety of DF injecta